This question appeared on the Diagnostic Equity website on 1-21-2026: “How well do peripheral blood platelet findings correlate with bone marrow fibrosis or megakaryocyte abnormalities in myelofibrosis, and when do lab results suggest a marrow reassessment might be useful?”
Diagnostic Equity expert Ryan J. Tom, MS, MLS(ASCP)CM (DCLS Resident) offered this answer: Platelet findings can be helpful for diagnosing possible bone marrow fibrosis. Myelofibrosis is an uncontrollable multiplication of stem cells within the bone marrow (BM). According to the Cleveland Clinic, the cells overpopulate the BM, which consequently reduces the amount of healthy cells produced by the BM (link: https://my.clevelandclinic.org/health/diseases/15672-myelofibrosis).
Platelets are blood cells that are affected by fibrosis. When a scientist in the laboratory reviews the blood film, they look for platelet abnormalities that can be indicative of marrow fibrosis. Abnormalities include large/giant platelets, hypogranular platelets (platelets without granules), abnormal cytoplasm color, abnormal clumping, and unusual shapes. While this doesn’t necessarily correlate with the type of marrow fibrosis or severity, it does indicate that something is occurring that affects normal platelet production.
Another tool that can be used to diagnose bone marrow fibrosis is the BM biopsy to review the cell population. The biopsy is also used to check for any genetic mutations that are commonly seen in myelofibrosis, such as JAK2, CALR, and MPL.
Overproduction of and abnormal megakaryocytes can be an aid for detecting myeloproliferative neoplasms. An overexpression of the TPO enzyme or an underexpression of the GATA-1 transcription factor can lead to increased production or abnormal production of megakaryocytes that can be seen in myelofibrosis, respectively (link: https://ashpublications.org/blood/article/120/9/1774/30861/Megakaryocyte-pathology-and-bone-marrow-fibrosis).
As for BM reassessment, it will be up to the oncologist if the BM needs to be reviewed once again. They would have to take into account many factors to come to a decision. They will monitor laboratory results, trends in laboratory values, and the overall physical picture. Based on all of these factors, they will determine the need for another bone marrow biopsy.
No comments here.